Didrovaltrate, CAS [[18296-45-2]]

Produktübersicht

• Artikelname: Didrovaltrate, CAS [[18296-45-2]]
• Artikelnummer: MCE-HY-N3741
• Hersteller Artikelnummer: HY-N3741
• Alternativnummer: MCE-HY-N3741-1MG,MCE-HY-N3741-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Didrovaltratum

Produktbeschreibung

Didrovaltrate (Didrovaltratum) is an L-type calcium channel blocker, ROS scavenger, autophagy enhancer, and lipid accumulation inhibitor. Didrovaltrate blocks L-type calcium currents in a concentration-dependent manner, shifts the current-voltage curve upward, modulates steady-state inactivation kinetics, and inhibits the nuclear translocation of glucocorticoid receptors. Didrovaltrate reduces ROS levels, downregulates the expression of muscle atrophy-related genes, enhances autophagy via lipophagy, and decreases Oleic acid-induced lipid accumulation. Didrovaltrate exhibits cytotoxic activity against cancer cells. Didrovaltrate can be used in research related to skeletal muscle atrophy, non-alcoholic fatty liver disease, breast cancer, lung cancer, gastric cancer, and prostate cancer[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 424.48
• Reinheit: 92
• CAS Nummer: [18296-45-2]
• Formel: C22H32O8
• Target-Kategorie: Autophagy,Calcium Channel,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Natural Products